Erschienen in:
01.09.2009 | Case Discussion
Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report
verfasst von:
Francesco G. De Rosa, Pierpaolo Terragni, Daniela Pasero, Anna C. Trompeo, Rosario Urbino, Anna Barbui, Giovanni Di Perri, V. Marco Ranieri
Erschienen in:
Intensive Care Medicine
|
Ausgabe 9/2009
Einloggen, um Zugang zu erhalten
Excerpt
Invasive aspergillosis (IA) is increasingly recognized in the intensive care unit (ICU), and new risk factors associated with respiratory colonization or infection by
Aspergillus spp. include steroid treatment and chronic lung obstructive disease [
1,
2]. In a review of 289 autopsies in the ICU, IA was the leading cause of Goldman class I discrepancy (a missed major diagnosis with major impact on patient management and survival) [
3]. …